Biopharmaceutical company Celgene has appointed Dr David Gillen as their new UK and Ireland Medical Director.
The appointment aims to reinforce the company’s commitment to its portfolio of products and use the experience of Dr Gillen to enhance its pipeline.
Samantha Pearce, Celgene General Manager in the UK and Ireland, says the new Medical Director is “one of the most well respected and experienced medical leaders” in the UK pharma industry.
Dr Gillen worked within the NHS as a physician for seven years before joining Pfizer’s R&D unit. In 2010, he joined Gilead Sciences as the Head of International Medical Affairs. “I am delighted to be appointed as Medical Director at Celgene and look forward to working with the team in an area that I’m passionate about,” he commented. “This is a very exciting time as Celgene’s portfolio expands and I can’t wait to build on the excellent work that’s already being undertaken.”
Share this article: